Accordingly, overexpression of LIMK1 in breast cancer cell lines MCF-7 and MDA-MB-231 increased their motility, while inhibition of LIMK1 attenuated this effect (Yoshioka et al., 2003). The gene discussed is LIMK1; the disease is breast carcinoma.